AIM ImmunoTech Inc. (AIM) Free cash flow 2016–2025
AIM ImmunoTech Inc. (AIM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.0MFY2025 · since FY2016: -$7.6M → -$11.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.0M | — |
| FY2023 | -$21.4M | -32.2% |
| FY2022 | -$16.1M | -15.5% |
| FY2021 | -$14.0M | -34.0% |
| FY2020 | -$10.4M | -14.5% |
| FY2019 | -$9.1M | +14.5% |
| FY2018 | -$10.7M | -31.6% |
| FY2017 | -$8.1M | -6.3% |
| FY2016 | -$7.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice